^
    6ms
    HFB-301001-01: A Study of HFB301001 in Adult Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=84, Active, not recruiting, HiFiBiO Therapeutics | Recruiting --> Active, not recruiting | Trial completion date: Jan 2024 --> Jan 2025 | Trial primary completion date: Jan 2024 --> Jan 2025
    Enrollment closed • Trial completion date • Trial primary completion date • Metastases
    |
    BRAF (B-raf proto-oncogene)
    |
    BRAF V600
    |
    HFB301001